Key facts
- Okami Medical’s last known valuation is $99.6M (Nov 2025).
- It has raised $103.9M across 6 recorded rounds; the latest was Early Stage VC ($28.9M) in Nov 2025.
- Notable investors include Gilde Healthcare, Inceptus Medical, Trinity Capital (Phoenix), U.S. Venture Partners, Vensana Capital.
- Okami Medical has filed 6 Form Ds with the SEC since 2019, most recently Sep 2024 ($18.6M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Okami Medical
Funding rounds
6 roundsAbout Okami Medical
Developer of a peripheral embolization device designed to treat cardiovascular disease for the occlusion of peripheral vessels. The company's device is used to obstruct or reduce the rate of blood flow in arteries of the peripheral vasculature and is highly stable after placement, enabling physicians to access and rapidly occlude a wide range of vascular targets.
- Sector
- Healthcare
- HQ
- Aliso Viejo, CA, United States
- Founded
- 2011
- Employees
- 8
- Website
- okamimedical.com/
- Ownership
- Privately Held (backing)
Okami Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Okami Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Okami Medical in its N-PORT filings yet. We sweep new filings monthly.